Brain Cancer Trial, Recruiting NCT04427384 Sponsor: GT Medical Technologies, Inc. Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT04427384
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had surgery to remove as much of a brain tumour as safely possible, with a radiation device called GammaTiles placed in the brain during that same surgery.
  • People who are willing and able to agree to take part and to attend all required assessments and check-ups.

Who may not be able to join:

  • People who are unable to have brain scans before and after surgery to check on the tumour and the implanted device.
  • People with serious physical health or mental health conditions that, in the opinion of the treating doctor, would prevent them from completing treatment or attending required assessments and follow-up visits.
  • People who, in the opinion of the treating doctor, are unable to understand the study or agree to take part, or who have a history of not following through with medical treatment or returning for follow-up care. (Note: A legally authorised representative may be able to provide consent on behalf of someone who cannot do so themselves — confirm with trial site.)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael A. Garcia, MD, MS, GT Medical Technologies

Phone: (833) 662-0044

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GT Medical Technologies, Inc.
Registry
ClinicalTrials.gov
Start date
11 September 2020
Est. completion
31 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Surgical Bed-Recurrence Free Survival in Metastatic Tumor Subjects; Surgical Bed-Recurrence Free Survival in Meningioma Tumor Subjects; Overall Survival in High Grade Glioma Subjects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov